50 Over 50. Top Colleges. Advisor. Advisor. See All. Best Credit Cards Of 2025. ... More Quinapril and Hydrochlorothiazide Tablets USP in 20 mg and 12.5 mg doses, respectively.

A potentially life-threatening label mix-up has led to a nationwide recall of a high blood pressure medication, according to the U.S. Food and Drug Administration.

The bottle was supposed to contain hydrochlorothiazide tablets USP 12.5 milligrams, a medication used to treat high blood pressure. Instead, they contained a different kind of diuretic ...

A shipment of Hydrochlorothiazide Tablets USP 12.5 mg distributed by Accord Healthcare Inc. is being voluntarily recalled after a 100 count bottle actually contained 100 Spironolactone Tablets ...

Wednesday, August 29th 2018, 10:50 am By: News 9 A batch of blood pressure medication is being recalled after it was potentially mixed up with a drug that could be deadly to some heart patients.

Accord Healthcare Inc. is voluntarily recalling one lot (Lot PW05264 – 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide tablets USP, 12.5 mg, because of a labeling mix-up. The medication ...

The U.S. Food and Drug Administration announced two more recalls of blood pressure medication Friday because potentially carcinogenic impurities were found in them. Skip to content.

East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg, to the ...

Accord Healthcare Inc. is voluntarily recalling one lot of 12.5 mg hydrochlorothiazide tablets after a 100-count bottle of the drug was found to contain 100 tablets of another drug, spironolactone.

One lot of blood pressure medication is being recalled after it was potentially mixed up with a drug that could be deadly to some heart patients. A shipment of Hydrochlorothiazide Tablets USP 12.5 ...